Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Biography

Meet the Section Editor

Author(s): Sergey Bachurin

Volume 22, Issue 10, 2024

Published on: 06 March, 2024

Page: [1577 - 1577] Pages: 1

DOI: 10.2174/1570159X2210240306123557

Price: $65

Next »
[1]
Makhaeva, G.F.; Kovaleva, N.V.; Rudakova, E.V.; Boltneva, N.P.; Lushchekina, S.V.; Astakhova, T.Y.; Timokhina, E.N.; Serkov, I.V.; Proshin, A.N.; Soldatova, Y.V.; Poletaeva, D.A.; Faingold, I.I.; Mumyatova, V.A.; Terentiev, A.A.; Radchenko, E.V.; Palyulin, V.A.; Bachurin, S.O.; Richardson, R.J. Combining experimental and computational methods to produce conjugates of anticholinesterase and antioxidant pharmacophores with linker chemistries affecting biological activities related to treatment of Alzheimer’s disease. Molecules, 2024, 29(2), 321.
[http://dx.doi.org/10.3390/molecules29020321]
[2]
Lapshina, M.A.; Shevtsova, E.F.; Grigoriev, V.V.; Aksinenko, A.Y.; Ustyugov, A.A.; Steinberg, D.A.; Maleev, G.V.; Dubrovskaya, E.S.; Goreva, T.V.; Epishina, T.A.; Zamoyski, V.L.; Makhaeva, G.F.; Fisenko, V.P.; Veselov, I.M.; Vinogradova, D.V.; Bachurin, S.O. New adamantane-containing edaravone conjugates as potential neuroprotective agents for ALS treatments. Molecules, 2023, 28(22), 7567.
[http://dx.doi.org/10.3390/molecules28227567]
[3]
Veselov, I.M.; Vinogradova, D.V.; Maltsev, A.V.; Shevtsov, P.N.; Spirkova, E.A.; Bachurin, S.O.; Shevtsova, E.F. Mitochondria and oxidative stress as a link between Alzheimer’s disease and diabetes mellitus. Int. J. Mol. Sci., 2023, 24(19), 14450.
[http://dx.doi.org/10.3390/ijms241914450]
[4]
Makhaeva, G.F.; Kovaleva, N.V.; Rudakova, E.V.; Boltneva, N.P.; Lushchekina, S.V.; Astakhova, T.Y.; Timokhina, E.N.; Serebryakova, O.G.; Shchepochkin, A.V.; Averkov, M.A.; Utepova, I.A.; Demina, N.S.; Radchenko, E.V.; Palyulin, V.A.; Fisenko, V.P.; Bachurin, S.O.; Chupakhin, O.N.; Charushin, V.N.; Richardson, R.J. Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer’s disease. Front. Pharmacol., 2023, 14, 1219980.
[http://dx.doi.org/10.3389/fphar.2023.1219980]
[5]
Makhaeva, G.F.; Kovaleva, N.V.; Rudakova, E.V.; Boltneva, N.P.; Grishchenko, M.V.; Lushchekina, S.V.; Astakhova, T.Y.; Serebryakova, O.G.; Timokhina, E.N.; Zhilina, E.F.; Shchegolkov, E.V.; Ulitko, M.V.; Radchenko, E.V.; Palyulin, V.A.; Burgart, Y.V.; Saloutin, V.I.; Bachurin, S.O.; Richardson, R.J. Conjugates of tacrine and salicylic acid derivatives as new promising multitarget agents for alzheimer’s disease. Int. J. Mol. Sci., 2023, 24(3), 2285.
[http://dx.doi.org/10.3390/ijms24032285]
[6]
Gupta, N.K.; Jayakumar, S.; Huang, W.C.; Leyssen, P.; Neyts, J.; Bachurin, S.O.; Hwu, J.R.; Tsay, S.C. Bis(Benzofuran-1,3-N,N-heterocycle)s as symmetric and synthetic drug leads against yellow fever virus. Int. J. Mol. Sci., 2022, 23(20), 12675.
[http://dx.doi.org/10.3390/ijms232012675]
[7]
Makhaeva, G.F.; Kovaleva, N.V.; Boltneva, N.P.; Rudakova, E.V.; Lushchekina, S.V.; Astakhova, T.Y.; Serkov, I.V.; Proshin, A.N.; Radchenko, E.V.; Palyulin, V.A.; Korabecny, J.; Soukup, O.; Bachurin, S.O.; Richardson, R.J. Bis-amiridines as acetylcholinesterase and butyrylcholinesterase inhibitors: n-functionalization determines the multitarget anti-alzheimer’s activity profile. Molecules, 2022, 27(3), 1060.
[http://dx.doi.org/10.3390/molecules27031060]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy